Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
- Conditions
- HIV Infections
- Registration Number
- NCT00038519
- Lead Sponsor
- Abbott
- Brief Summary
The purpose of this study is to study the safety and efficacy of Amprenavir/ritonavir or saquinavir/ritonavir in HIV infected patients that have failed Kaletra as their second protease inhibitor based HAART.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Proportion of subjects with plasma HIV RNA levels below the limit of quantification (400 copies/mL) at week 24 and the time until loss of virologic response through week 48
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (52)
Toronto General Hospital Division of The University Health Network
🇨🇦Toronto, Ontario, Canada
Phillip Sestak, M.D
🇨🇦Vancouver, British Columbia, Canada
Wojewodzki Szpital Zakazny
🇵🇱Warszawa, Poland
Hospital Muniz - FUNDAI
🇦🇷Buenos Aires, Argentina
Hospital Tenon
🇫🇷Paris, France
AIDS Health Care Foundation - Research Center
🇺🇸Los Angeles, California, United States
New Puerto Rico CONCRA
🇵🇷Rio Piedras, Puerto Rico
IRCCS "L. Spallanzani"
🇮🇹Rome, Italy
University of Colorado Health Sciences Center
🇺🇸Denver, Colorado, United States
Ottawa Hospital General Campus
🇨🇦Ottawa, Ontario, Canada
Service du C.I.S.I.H. - C.H.U. de Grenoble
🇫🇷La Tronche, France
Hospital Yves Le Foll
🇫🇷Saint Brieuc, France
AIDS Research Consortium of Atlanta, Inc.
🇺🇸Atlanta, Georgia, United States
Montreal Chest Institute/Royal Victoria Hospital
🇨🇦Montreal, Quebec, Canada
Donna E. Sweet, M.D.
🇺🇸Wichita, Kansas, United States
State University of New York at Stony Brook
🇺🇸Stony Brook,, New York, United States
David Wright, M.D.
🇺🇸Austin, Texas, United States
Fundacion Huesped
🇦🇷Buenos Aires, Argentina
Hospital De La Sta Creu I San Pau
🇪🇸Barcelona, Spain
Hospital Heliopolis
🇧🇷Sao Paulo, Brazil
Associates in Research
🇺🇸Fort Myers, Florida, United States
Howard A. Grossman, M.D.
🇺🇸New York, New York, United States
David Parks, M.D.
🇺🇸St. Louis, Missouri, United States
20th Avenue Medical Center Kaiser Permanente
🇺🇸Denver, Colorado, United States
La Seyne sur Mer, Hopital Chalucet
🇫🇷Toulon, France
Centro Familiar, Inc
🇵🇷Ponce, Puerto Rico
S. Raffaele Hospital
🇮🇹Milan, Italy
Hospital do Servidor Publico Estadual de Sao Paulo
🇧🇷Sao Paulo, SP, Brazil
Groupe Hospitalier Cochin -Saint-Vincent-de-Paul La Roche-Guyon
🇫🇷Paris, France
Hospital La Paz
🇪🇸Madrid, Spain
Bornemann Internal Medicine
🇺🇸Reading, Pennsylvania, United States
Hospital Universitario Vergen del Rocio
🇪🇸Sevilla, Spain
III Infectious Diseases Division IRCCS "L. Spallanzani"
🇮🇹Rome, Italy
Hospital Germans Trias I Pujol
🇪🇸Badalona, Spain
Hospital "Amedeo di Savoia"
🇮🇹Torino, Italy
Hospital Clinic I Provincial
🇪🇸Barcelona, Spain
Hospital Carlos III
🇪🇸Madrid,, Spain
Royal Free Hospital
🇬🇧London, United Kingdom
University of Miami School of Medicine
🇺🇸Miami, Florida, United States
CORE Center
🇺🇸Chicago, Illinois, United States
University of Cincinnati Medical Center
🇺🇸Cincinnati, Ohio, United States
Diversified Medical Practices, P.A.
🇺🇸Houston, Texas, United States
IDC Research Initiative
🇺🇸Altamonte Springs, Florida, United States
Infectious Disease Research Institute, Inc.
🇺🇸Tampa, Florida, United States
Phoenix Body Positive, Inc.
🇺🇸Phoenix,, Arizona, United States
Gary J. Richmond, M.D.
🇺🇸Ft. Lauderdale, Florida, United States
The Research & Education Group
🇺🇸Portland, Oregon, United States
Hampton Roads Medical Specialists
🇺🇸Hampton, Virginia, United States
Hospital Evandro Chagas - Fiocryz
🇧🇷Rio de Janeiro, Brazil
Saint Michael's Medical Center
🇺🇸Newark, New Jersey, United States
John B. Montana, M.D.
🇺🇸New York,, New York, United States
Tour Drouet - C.H.U. Brabois
🇫🇷Vandoeuvre, Cedex, France